InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Veillon-Berteloot Chantal. Director active across 1 company, notably Integra Lifesciences Holdings CORP. Aggregated, 4 reports have been recorded. History available since 1 September 2023. The latest transaction was filed on 11 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations